N/A
N=15
Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus)
Coronavirus
Bottom Line
View on ClinicalTrials.gov: NCT04337489 ↗Enrolled (actual)
15
Serious AEs
0.0%
Results posted
Oct 2024
Primary outcome: Primary: Deterioration Resulting in Healthcare Review — 10 alerts generated
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- SensiumVitals wearable sensor (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Imperial College London
- Primary completion
- Mar 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Deterioration Resulting in Healthcare Review |
10 | — |
| SECONDARY Hospitalisation |
— | — |
Summary
The study aims to see if participant deterioration due to suspected coronavirus in a designated location (e.g. hotel) can be identified sooner by wearing the sensor. If sick patients can be identified early, participants are more likely to have better outcomes; the study believes that the sensor can help us do this. The sensor measures heart rate, respiratory rate and temperature every 2 minutes and this can be reviewed by the clinical team looking after the participants.
Eligibility Criteria
Inclusion Criteria
- Aged 18 years or over.
- Able to provide written consent.
Exclusion Criteria
- Any participants that withdraw their consent.
- A skin condition/reaction preventing wearing the wearable sensor.
- The presence of a permanent pacemaker or cardiac defibrillator.
- Any form of psychiatric disorder or a condition that, in the opinion of the investigator, may hinder communication with the research team.
- Inability to cooperate or communicate with the research team.
Data sourced from ClinicalTrials.gov (NCT04337489). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.